We previously showed the presence of receptors for granulocyte-macrophage colony-stimulating factor (GM-CSF) on tumor tissues and tumor cell lines that are derived from the neural crest. To determine whether normal neural cells express functional GM-CSF receptors, we isolated and analyzed primary rat brain cells, including microglia, astrocytes, and oligodendrocytes. Scatchard analysis of equilibrium binding of '251-GM-CSF to primary rat oligodendrocytes showed an average of 1.1 10 GM-CSF binding sites per cell, with a kd of 20 pmol/L. In six separate experiments, no specific binding was detectable on the astrocyte population. Microglia were used in competitive binding experiments with oligodendrocytes, and addition of microglia did not increase the specific binding of HE COLONY-STIMULATING factors (CSFs) stimu-T late proliferation and maturation of hematopoietic precursors and the function of mature myeloid cells.'-4 The fact that receptors for CSFs are expressed in nonhematopoietic tissues suggests that these regulators are important in the physiology of some cell types not derived from the hematopoietic stem cell. Thus, CSF receptor-expressing cells are found in placenta, endothelium, the central nervous system (CNS), and various nonhematopoietic tumor cell^.^-^ We previously described granulocyte-macrophage colony-stimulating (GM-CSF) receptors on cells derived from the neural crest, including small cell carcinoma of the lung cell lines and primary melanoma cell^.^,'^ Glial cells of the CNS provide neurons with both structural and protective support," and subpopulations of glial cells have been implicated in immunologic reactions causing or resulting from brain i n J~r y . '~-'~ The glial compartment is composed of astrocytes, oligodendrocytes, and microglia (phagocytic cells mobilized in response to injury). Fibrous astrocytes and oligodendrocytes develop from a common progenitor, whereas brain macrophages and microglia arise from hematopoietic precursors. Morphologic hallmarks of inflammatory and degenerative diseases of the brain are hypertrophy of astrocytes and accumulation of macrophages, the latter being recruited from circulating blood monocytes and from microglia. Although initially mature oligodendrocytes in the adult mammalian CNS were thought to be postmitotic and unable to proliferate in response to injury, more recent studies have shown that mature oligodendrocytes are able to respond to CNS trauma or disease by proliferating and producing myelin.'5v'6 The neuroepithelial-derived cells and the hematopoietic-derived lymphocytes and mononuclear phagocytes comprise the basic mileau of the CNS. Thus, many of the cellular and humoral regulatory functions of the lymphohematopoietic system of the body are recapitulated in the brain.
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Various types of glial cells respond to cytokines, most notably the immunoregulatory interleukins (ILs): IL-1, IL-2, IL-3, and IL-6."3'7-24 Additionally, IL-1-or tumor necrosis factor (TNF) stimulated astrocytes produce hematopoilabeled ligand to oligodendrocytes. In dose-response assays, we measured %-thymidine uptake in rat oligodendrocytes, microglia and control murine 32D cells stimulated with various concentrations of GM-CSF. Over concentration ranges of 0.025 to 1000 pmol/L, cell proliferation and peak 3H-thymidine incorporation was observed at approximately 30 pmol/L for both the control cells and the oligodendrocytes. However, the microglial cells did not proliferate in response to GM-CSF. These data indicate the presence of a functional receptor for GM-CSF on primary rat oligodendrocytes, and suggest that hematopoietic growth factors such as GM-CSF may play a role in nerve cell development, function, or response to injury. etic growth factor^.'^,^^ In this report, we show GM-CSF receptor expression and GM-CSF responsiveness in primary rat oligodendrocytes, suggesting that hematopoietic growth factors may function during trauma to the CNS to induce proliferation of oligodendrocytes and remyelination.
MATERIALS AND METHODS

Cells and cytokines.
Primary glial-cell cultures were established from neonatal rat cerebra by a modification of the method by McCarthy and deVellis.26 Briefly, meninges were removed from the cerebra before culture. After 7 days in primary culture, oligodendrocytes and microglia were separated from astrocytes by mechanical dislodging, and resuspended in culture medium consisting of Dulbecco's modified essential medium, Ham's medium, 1 % glutamine, 0.1% gentamycin and 10% fetal bovine serum (FBS). The oligodendrocytes, which constitute 10% of the mixed glial culture, were separated from the microglia by a brief adherence step (37°C for 20 minutes For personal use only. on October 23, 2017. by guest www.bloodjournal.org From be up to 99% pure, as determined by immunofluorescence staining for galactocerebroside, a myelin-associated galactosphengolipid that is a surface antigen specific for oligodendrocytes. The factordependent murine myeloid cell line, 32D clone 3, a gift from S. Greenberger (University of Pittsburgh Medical Center, Pittsburgh, PA), was maintained in Iscove's modified Dulbecco's media (IMDM) supplemented with 10% FBS, glutamine, antibiotics, and murine GM-CSF (approximately 200 pmol/L). Purified recombinant murine GM-CSF (expressed in Escherichia coli) was provided by J.J. Mermod (Glaxo Institute for Molecular Biology, Geneva, Switzerland).
The method for measuring uptake of 'Hthymidine was described previously.' Test cells ( lo4) were incubated in media without serum in 96-well flat-bottomed microtiter trays. After 12 hours, murine GM-CSF was added at concentrations indicated. Cells were incubated in the presence of GM-CSF for 36 hours at 37°C in a humidified atmosphere with 5% COz; DNA synthesis in the culture was determined by addition of [methyl-'HIthymidine (0.5 pCi per well) for a 12-hour pulse. Cells were harvested onto glass fiber filters and counted in liquid scintillation fluid.
Equilibrium binding and cross-linking assays. For equilibrium
binding assays, a previously described method' was used with the following modifications. Recombinant murine GM-CSF was iodinated using lactoperoxidase and glucose oxidase. Specific activity (1.75 to 3.50 X IO5 cpm/ng) was determined by self-displacement analysis using 32D cells. In receptor cross-linking analysis, oligodendrocytes, 32D cells and 1251-labeled GM-CSF were prepared as described. 1Z51-GM-CSF (final concentration 100 pmol/L) was added to lo7 oligodendrocytes and lo7 32D cells. Unlabeled GM-CSF (final concentration 50 nmol/L) was added to duplicate tubes of each cell type. After equilibrium binding (4°C for 3 hours), the cell pellets were washed and incubated with disuccinimidyl suberate (DSS) at a final concentration of 0.15 mmol/L. The cross-linking reaction was quenched after the addition of cold 0.25 mmol/L sucrose, 10 mmol/L Tris, 1 mmol/L EDTA pH 7 with 1 mmol/L PMSF and 10 pg/mL leupeptin. The pellets were solubilized in a minimal volume of Triton X-100 (1%) (Sigma Chemical CO, St Louis, MO), the nuclei discarded, and the lysate saved. Samples (diluted 1:l with sample buffer) were run on a Bio-Rad mini-PROTEAN I1 Ready Gel (Bio-Rad Laboratories, Hercules, CA).
Proliferafive assays.
RESULTS
Analysis of in vitro interaction of GM-CSF with oligodendrocytes. Cell growth and 'H-thymidine incorporation
were maximally stimulated by GM-CSF in both the primary rat oligodendrocytes and control 32D cells at a concentration of approximately 30 pmol/L (Fig 1) . One representative experiment is shown, but similar results were obtained in three repeat experiments. The decrease in oligodendrocyte 'H-thymidine incorporation seen at the higher concentrations, however, was not a reproducible observa- tion. Neither the microglia nor the astrocytes (not shown) were stimulated by GM-CSF.
The in vitro interaction of GM-CSF with rat oligodendrocytes was defined by Scatchard analysis of equilibrium binding of 12'I-GM-CSF to oligodendrocytes (Fig 2) . The oligodendrocytes expressed a single class of high-affinity receptor for GM-CSF. Scatchard analysis of a representative experiment estimates 1,100 binding sites per cell, with a kd of 20 pmol/L (mean kd = 38.05 f 8.05 pmol/L with 703 f 141 sites/cell; n = 7), in close agreement with the control, the factor-dependent myeloid cell line 32D: 297 sites/cell, kd = 3 1 pmol/L (mean kd = 3 1.90 k 5.2 1 pmol/L with 472 f 130 sites/cell; n = 4). These data cannot be explained by contamination of the oligodendrocyte preparation with microglia, because the microglia represent less than 2% of the total cells. Furthermore, in binding analysis using purified microglia, there was no detectable specific binding to 12'I-GM-CSF. In mixing experiments with equal numbers of oligodendrocytes and microglia, addition of the microglia did not increase the specific binding of the mixed-glial culture to "'I-GM-CSF but, in fact, decreased it when compared with the specific binding obtained with oligodendrocytes alone. The astrocytes, which may be capable of producing GM-CSF as well as other ~ytokines,~' do not have detectable binding of I2'I-GM-CSF.
Characterization of GM-CSF receptors on oligodendrocytes. To characterize the structure of the GM-CSF receptors expressed on oligodendrocytes, "'1-GM-CSF was cross-linked to these primary neural cells using the homobifunctional cross-linker, DSS. '*'I-GM-CSF affinity-labeled receptor complexes from oligodendrocytes (Fig 3, lanes A  and B) and control 32D cells (Fig 3, lanes C and D) were solubilized, and total cell lysates were fractionated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
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(SDS-PAGE) after equilibrium binding in the absence (lanes A and C) and presence of excess unlabeled murine GM-CSF (lanes B and D). Major specific-labeled bands competed by unlabeled GM-CSF were seen at approximately 70 to 75 kD and 45 to 50 kD. Given a molecular weight of 14 kD for unglycosylated murine GM-CSF, these bands would correspond to molecular weights of approximately 60 and 30 kD, respectively, and the structural configuration of the GM-CSF receptor appears to be the same for hematopoietic cells and primary neural cells. Park et alZ* estimate the size of the cloned murine GM-CSF receptor to be 50 to 60 kD. The lower band (30 kD) is likely to be a cleavage product.
DISCUSSION
In this report, we demonstrate the presence of functional GM-CSF receptors on the surface of primary rat oligodendrocytes. The affinity of the binding sites correlates well with the concentrations of GM-CSF that stimulate 3H-thymidine uptake in vitro. Additionally, proposed molecular weights for the GM-CSF receptor expressed on neural cells are in agreement with receptor molecular weights on hematopoietic cells. This study extends our previous observations on tumor cells derived from the neural crest" and confirms is the murine-dominant white spotting W locus, which is known to affect the development of hematopoietic, germ, and neural crest-derived lineages." This phenotype is caused by mutations in the c-kit gene, which encodes the transmembrane tyrosine kinase receptor for stem cell facSeveral other reports indicate that the transition from regulation of hematopoiesis to regulation of neuropoiesis is within the functional scope of hematopoietic growth factors. The converse may also be true; nerve growth factor has been shown to promote human hematopoietic colony growth and differentiati~n.""~ In the nervous system, glial cells both produce and respond to immunoregulatory cytokines.'7-24.27 For example, the microglia, a likely target cell for hematopoietic growth factors, expresses the receptor for CSF-I, ~~f i n s ,~~ and responds to CSF-I in vitro.36 Additionally, production of GM-CSF and G-CSF by microgliaz5 is consistant with their presumed hematopoietic ontogeny and their putative role as the macrophage of the CNS. If the microglia are producing GM-CSF, receptor expression may be downregulated, thus explaining our inability to detect specific binding or biologic response. However, we do show both response and receptor expression in the myelin-producing oligodendrocytes, setting the stage for a paracrine phenomenom activated in response to injury.
Our results provide support for the concept of a cytokine network within the CNS analogous to that seen in hematopoiesis. Maintenance of the normal cytokine balance may
